Search for: "Anda Pharmaceuticals, Inc"
Results 541 - 560
of 607
Sorted by Relevance
|
Sort by Date
1 Mar 2011, 3:24 pm
., v Cobrek Pharmaceuticals Inc., (NDIL, Order 2/17/11), the relatively rare case of a Patentee requested stay was at issue. [read post]
19 Jan 2007, 5:18 am
The Act permits companies that would like to offer a generic drug that is the bioequivalent of a brand company's drug to make an Abbreviated New Drug Application (ANDA) that includes a statement of the generic's views concerning the patent status of the brand drug. [read post]
29 Aug 2012, 10:09 pm
District Court for the District of New Jersey concerning Wyeth Pharmaceuticals Inc. [read post]
19 Mar 2012, 1:31 am
Wyeth, Inc., No. 09-cv-0854 (W.D. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
17 Apr 2012, 5:55 pm
” The Court says that its decision is consistent with the circumstances surrounding the aftermath of the Federal Circuit’s decision in Mylan Pharmaceuticals, Inc. v. [read post]
19 Jul 2010, 1:12 pm
Court of Appeals for the Federal Circuit denied Lupin Pharmaceuticals, Inc. [read post]
25 Jul 2007, 3:15 pm
Astra offers no convincing reason why Emert does not apply.2 See also Geneva Pharms., Inc. v. [read post]
11 Aug 2011, 5:25 pm
As we previously reported, the statutory counterclaims provisions were recently asserted in the context of a 505(b)(2) application for Intelliject, Inc. [read post]
7 Jul 2011, 3:38 pm
District Court for the District of New Jersey issued a 19-page decision in Nostrum Pharmaceuticals, LLC. v. [read post]
18 Apr 2017, 6:52 am
See Ariad Pharms., Inc. v. [read post]
15 Apr 2010, 7:04 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
11 Apr 2013, 7:38 am
In re Armodafinil Patent Litigation Inc. [read post]
8 Jul 2015, 8:31 am
Inc. v. [read post]
Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test
30 Apr 2019, 7:10 pm
In Vanda Pharmaceuticals Inc. v. [read post]
4 Nov 2010, 1:24 pm
Wyeth, Inc., 85 Cal. [read post]
12 Jun 2014, 10:41 am
Teva Pharmaceuticals USA, Inc. [read post]
2 Nov 2020, 1:41 pm
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
5 Apr 2012, 11:54 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
